AMC enters September with a notable analyst upgrade and a steady short squeeze in progress — yet the stock still drifted 2.6% lower on the week to $2.58.
Macquarie's Chad Beynon is the headline mover this week. He raised his price target on AMC to $3.00 from $2.50 — the second hike in under two months — while holding a Neutral rating. That move, filed Tuesday, puts his target meaningfully above the current price and nudges the Street's consensus mean to $2.72. The broader analyst picture remains split. Wedbush carries an Outperform with a $4.00 target. Benchmark sits at Buy with $3.00. Citi stays at Sell with a $1.20 target. No one is rushing to upgrade the rating itself — the direction of travel on price targets has been upward, but the conviction to turn outright bullish is still limited.
The bull case centres on margin recovery. EBITDA is projected to grow 53% in 2026 as a strong film slate drives attendance and fixed-cost leverage kicks in. Net leverage has improved to 9.3x and is expected to approach 7x by year-end. The bear case is harder to ignore: AMC is still guiding toward a negative adjusted EBITDA figure despite revenue growth, attendance remains structurally challenged, and quantitative models flag it as overvalued relative to peers. The EV/EBITDA multiple is running at 13.6x, the PE is negative, and the EPS momentum factor scores sit at the 27th and 6th percentiles over 30 and 90 days respectively — forward revisions have turned lower even as the 12-month forward earnings growth rank is high at the 78th percentile. That tension between a recovering top line and stubbornly negative earnings is the central debate.
Short positioning tells a quieter story this week. Short interest fell roughly 11% across the week to 8.0% of the free float — a real decline, dropping from nearly 46–47 million shares shorted in mid-August to just over 41 million now. That retreat coincided with the stock's month-long slide from higher levels, suggesting cover rather than fresh conviction. Borrowing costs remain very low at 0.59%, and availability is exceptionally loose at around 949% — for every share currently borrowed, there are roughly nine and a half available. There is no squeeze pressure here. The ORTEX short score has drifted down from around 39.4 to 37.8 over the past two weeks, consistent with a market that is gently unwinding short exposure rather than piling in. The 52-week minimum availability was a near-total lockout at 0.05%, which underscores just how different the current setup is from prior stress episodes.
The peer group also had a rough week. CNK fell 7.0% and MCS dropped 8.0%. AMC's 2.6% decline looks relatively contained by comparison, even if the direction is the same. The exhibition sector as a whole appears to be digesting a softer patch after the earlier 2026 rally.
Institutional ownership adds an interesting backdrop. BlackRock crossed back above 5% in a 13G/A filed in late July, reporting a 5.5% stake — a significant reversal from Goldman Sachs, which cut its disclosed position from 6.5% to 1.3% as of May 2025. Discovery Capital Management trimmed from 8.0% to 5.8% in its most recent 13G/A, while Pentwater Capital slashed from roughly 10% to just 0.3%. The register carries the standard caveat: these are event-driven disclosures around the 5% threshold, and holders who drift below that level may not file again. The large new entry from BlackRock is the most structurally interesting development. As a passive manager, it may simply reflect index reconstitution — but the size of the change (from what appeared to be a much smaller position) is worth noting alongside the active trimming by hedge funds like Pentwater.
Next earnings are scheduled for November 6. The two most recent prints produced opposite reactions: the August 4 report sent the stock down 6% on the day and 16% over five days, while the July 20 event (an earlier or amended filing) generated a 13% one-day rally and a 29% five-day move. The next print will focus on whether the blockbuster-driven margin recovery is arriving on schedule or whether attendance trends are lagging the optimistic 2026 projections.
See the live data behind this article on ORTEX.
Open AMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
